Bill Gates on Eli Lilly pausing antibody trial due to safety concerns

Bill Gates joined CNBC's Becky Quick to discuss Eli Lilly's decision to pause its trial for a coronavirus antibody treatment due to safety concerns. They also discuss the Bill and Melinda Gates Foundation's work with Eli Lilly to assist with mass distribution of the company's antibody treatment.
01:59
Wed, Oct 14 20207:15 AM EDT